25 May 2013
Keywords: targacept, announces, positive, mecamylamine, hcl, data, clinical-stage
Article | 30 July 2007
US clinical-stage biopharmaceutical company Targacept says that data suggest that mecamylamine HCl, a broad spectrum nicotinic antagonist, improves the symptoms ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.